The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 15, 2016

Filed:

Jun. 03, 2011
Applicants:

Mark J. Papania, Lilburn, GA (US);

James J. Barry, Hanover, NH (US);

Mark C. Bagley, Grafton, NH (US);

Eric M. Friets, Norwich, VT (US);

Darin A. Knaus, Norwich, VT (US);

Inventors:

Mark J. Papania, Lilburn, GA (US);

James J. Barry, Hanover, NH (US);

Mark C. Bagley, Grafton, NH (US);

Eric M. Friets, Norwich, VT (US);

Darin A. Knaus, Norwich, VT (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 15/08 (2006.01); A61B 1/233 (2006.01); A61M 11/00 (2006.01); A61B 1/04 (2006.01); A61B 1/06 (2006.01); A61M 15/00 (2006.01); A61M 16/04 (2006.01); A61M 16/00 (2006.01);
U.S. Cl.
CPC ...
A61B 1/233 (2013.01); A61B 1/04 (2013.01); A61B 1/06 (2013.01); A61M 11/00 (2013.01); A61M 11/005 (2013.01); A61M 11/007 (2014.02); A61M 15/0098 (2014.02); A61M 15/08 (2013.01); A61M 16/0488 (2013.01); A61M 2016/0024 (2013.01); A61M 2016/0042 (2013.01); A61M 2205/3365 (2013.01); A61M 2205/3375 (2013.01); A61M 2205/43 (2013.01); A61M 2205/502 (2013.01); A61M 2205/581 (2013.01); A61M 2205/6036 (2013.01); A61M 2205/6054 (2013.01); A61M 2205/6063 (2013.01);
Abstract

A nasal delivery device can include a nasal prong and an activation member. The nasal prong can comprises an opening at a top and bottom portion of the prong to allow for the passage of an aerosolized treatment agent through the nasal prong. The activation member can be positioned on the nasal delivery device at a location that is spaced apart from the subject's oral cavity when the nasal prong is received into the nostril of the subject. The activation member can be configured to detect a desired exhalation state of the subject and upon detection of the desired exhalation state, the activation member activates the delivery of the aerosolized treatment agent.


Find Patent Forward Citations

Loading…